Roche's Foundation Medicine wins FDA blessing for new cancer test
December 04, 2017 at 01:33 AM EST
ZURICH, Dec 4 (Reuters) - Roche on Monday said its Foundation Medicine unit won U.S. Food and Drug Administration (FDA) approval for a test to help doctors understand the genetic profile of patients' tumours and guide them to effective therapies.
